KLA Corporation Other Non-Current Liabilities increased by 6.9% to $708.66M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.0%, from $632.47M to $708.66M. Over 4 years (FY 2021 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a -0.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $631.29M | $620.58M | $650.81M | $642.17M | $882.64M | $881.77M | $807.45M | $1.00B | $813.06M | $739.10M | $807.17M | $773.21M | $743.12M | $651.07M | $639.12M | $632.47M | $609.63M | $646.09M | $662.67M | $708.66M |
| QoQ Change | — | -1.7% | +4.9% | -1.3% | +37.4% | -0.1% | -8.4% | +24.1% | -18.9% | -9.1% | +9.2% | -4.2% | -3.9% | -12.4% | -1.8% | -1.0% | -3.6% | +6.0% | +2.6% | +6.9% |
| YoY Change | — | — | — | — | +39.8% | +42.1% | +24.1% | +56.0% | -7.9% | -16.2% | -0.0% | -22.8% | -8.6% | -11.9% | -20.8% | -18.2% | -18.0% | -0.8% | +3.7% | +12.0% |